Characteristics | All patients (n = 253) | Propensity-matched patients (n = 191) | ||||
---|---|---|---|---|---|---|
PIMs use group (n = 107) | PIM non-use group (n = 146) | p | PIMs use group (n = 107) | PIMs non-use group (n = 84) | p | |
Age (year) | 75.6 ± 8.6 | 72.8 ± 7.7 | 0.1141) | 75.6 ± 8.6 | 73.4 ± 7.7 | 0.1121) |
Sex, female | 93 (86.6) | 124 (85.3) | 0.7182) | 93 (86.6) | 72 (81.6) | 0.3952) |
Fracture type, n (%) | 0.0192) | 0.1102) | ||||
AO type A | 10 (9.3) | 3 (2.1) | 10 (9.3) | 2 (2.2) | ||
Type B | 42 (39.3) | 52 (35.6) | 42 (39.3) | 40 (46.0) | ||
Type C | 55 (51.4) | 91 (62.3) | 55 (51.4) | 42 (48.3) | ||
BMI (kg/m2) | 22.4 ± 3.7 | 22.2 ± 3.8 | 0.8421) | 22.4 ± 3.7 | 22.2 ± 3.6 | 0.5611) |
Serum albumin (g/dl) | 4.03 ± 0.44 | 4.09 ± 0.32 | < 0.0011) | 4.03 ± 0.44 | 4.07 ± 0.32 | 0.3261) |
BMD (g/cm2) | 0.89 ± 0.15 | 0.89 ± 0.15 | 0.9211) | 0.89 ± 0.15 | 0.89 ± 0.14 | 0.4761) |
CCI | 0.57 ± 0.70 | 0.57 ± 0.70 | < 0.0011) | 0.57 ± 0.70 | 0.30 ± 0.57 | 0.011) |
Total number of drugs administered on admission | 5.45 ± 2.72 | 5.45 ± 2.72 | 0.1781) | 5.45 ± 2.72 | 3.41 ± 2.62 | < 0.0011) |
Use of drugs for osteoporosis, n (%) | 20 (18.7) | 22 (15.1) | 0.4442) | 20 (18.7) | 12 (14.3) | 0.4182) |
Length of hospital stay | 2.29 ± 2.06 | 1.76 ± 0.89 | 0.0061) | 2.29 ± 2.06 | 1.83 ± 0.91 | 0.0611) |
BI score | ||||||
Admission | 77.2 ± 7.89 | 77.8 ± 6.08 | 0.0591) | 77.2 ± 7.89 | 77.3 ± 6.41 | 0.7201) |
1 year after surgery | 85.3 ± 9.03 | 87.4 ± 8.29 | 0.7471) | 85.3 ± 9.03 | 87.3 ± 8.75 | 0.1171) |
BI gain | 9.66 ± 5.80 | 8.04 ± 4.94 | 0.1831) | 9.66 ± 5.80 | 10.0 ± 5.60 | 0.0061) |
Mayo wrist score | ||||||
1 year after surgery | 83.1 ± 6.72 | 84.7 ± 6.40 | 0.0601) | 83.1 ± 6.72 | 84.7 ± 6.40 | 0.1321) |
Subsequent falls, n (%) | 24 (22.4) | 13 (8.9) | 0.0032) | 24 (22.4) | 7 (8.0) | 0.0092) |